Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: Mexico
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Roche Holding AG

+ Add to Watchlist


Price not available for RHHBYN:MM

Snapshot for Roche Holding AG (RHHBYN)

Open: - Day's Range: - Volume: 0
Previous Close: 450.86 52wk Range: - 1-Yr Rtn: -

Stock Chart for RHHBYN

No chart data available.
  • 1M
  • 1Y
Interactive RHHBYN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RHHBYN

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 15.7819
Relative P/E vs. MEXBOL -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2015) 1.8090
Est. PEG Ratio 3.0915
Market Cap (M MXN) 3,589,037.79
Shares Outstanding (M) 5,620.50
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.62%
Cash Dividend (USD) 0.8942
Dividend Ex-Date 03/04/2015
5 Year Dividend Growth 12.83%
Next Earnings Announcement 07/23/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RHHBYN

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for RHHBYN

Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, and respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.

Severin SchwanChief Executive OfficerAlan HippeChief Financial & IT Officer
Roland DiggelmannCOO:DiagnosticsGottlieb A KellerGeneral Counsel
More Company Profile & Key Executives for RHHBYN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil